pcr-hpv massarray (agena bioscience)
agena bioscience is a verified supplier 
agena bioscience manufactures this product 
90
Structured Review
agena bioscience
pcr-hpv massarray
Pcr Hpv Massarray, supplied by agena bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hpv+massarray/pcr+hpv+massarray/pmc10447222-33-23-25
Average 90 stars, based on 1 article reviews
Pcr Hpv Massarray, supplied by agena bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hpv+massarray/pcr+hpv+massarray/pmc10447222-33-23-25
Average 90 stars, based on 1 article reviews
pcr-hpv massarray - by Bioz Stars,
2026-10
90/100 stars
Images
1) Product Images from "Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis"
Article Title: Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis
Journal: The Lancet. Global Health
doi: 10.1016/S2214-109X(23)00305-4
Figure Legend Snippet: Studies included reporting prevalence of genital HPV in men by UN Sustainable Development Goals regional grouping
Techniques Used: Selection, Real-time Polymerase Chain Reaction, Multiplex Assay, Northern Blot, Diagnostic Assay, Luminex, Hybridization, DNA Sequencing, Infection, Sampling, Stripping Membranes, Control
Related Articles
Polymerase Chain Reaction:Article Title: HPV Detection in Oropharyngeal Cancer: A Narrative Review of Diagnostic and Emerging Molecular Approaches. Article Snippet: 5-year OS: p16+/HPV+ 81%, p16−/HPV− 40%, p16+/HPV− 55%, p16−/HPV+ 53%. Bhardwaj et al. [29] Consecutive clinical series OPSCC, sinonasal, CUP (n = 746) p16 IHC; HPV DNA PCR; E6/E7 RNA ISH; genotyping ( Mass Spectrometry:Article Title: HPV Detection in Oropharyngeal Cancer: A Narrative Review of Diagnostic and Emerging Molecular Approaches. Article Snippet: 5-year OS: p16+/HPV+ 81%, p16−/HPV− 40%, p16+/HPV− 55%, p16−/HPV+ 53%. Bhardwaj et al. [29] Consecutive clinical series OPSCC, sinonasal, CUP (n = 746) p16 IHC; HPV DNA PCR; E6/E7 RNA ISH; genotyping ( Amplification:Article Title: HPV Detection in Oropharyngeal Cancer: A Narrative Review of Diagnostic and Emerging Molecular Approaches. Article Snippet: 5-year OS: p16+/HPV+ 81%, p16−/HPV− 40%, p16+/HPV− 55%, p16−/HPV+ 53%. Bhardwaj et al. [29] Consecutive clinical series OPSCC, sinonasal, CUP (n = 746) p16 IHC; HPV DNA PCR; E6/E7 RNA ISH; genotyping ( |